Close Menu

NEW YORK — Centogene last week filed to go public in the US through an offering of up to $69 million of its common stock.

In its filing with the US Securities and Exchange Commission, however, Centogene noted that it has not finalized the number of shares it intends to offer or the price per share.

SVB Leerink and Evercore ISI are listed in the filing as the underwriters for the IPO.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.